Traders Buzzing Ahead of 1PM FDA Media Briefing (VVUS)
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
Traders are buzzing after the FDA announced a 1PM media briefing "to discuss an important FDA regulatory aciton by the Center for Drug Evaluation and Research."
Some think it could be related to VIVUS Inc. (Nasdaq: VVUS), which has a PDUFA date for obesity drug Qnexa. Others note that the breiing includes antiviral experts.
Some think it could be related to VIVUS Inc. (Nasdaq: VVUS), which has a PDUFA date for obesity drug Qnexa. Others note that the breiing includes antiviral experts.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly’s Retevmo approved by FDA for RET Tumors
- Veradermics to host call on Phase 2 hair loss drug trial results
- FDA grants priority review to Genentech's Gazyva for kidney disease
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
